A Clinical Trial of Freeze-dried Human Rabies Vaccine (MRC-5 Cells)

PHASE3CompletedINTERVENTIONAL
Enrollment

1,880

Participants

Timeline

Start Date

October 19, 2019

Primary Completion Date

July 21, 2021

Study Completion Date

September 26, 2022

Conditions
Rabies Vaccine Adverse Reaction
Interventions
BIOLOGICAL

Freeze-dried human rabies vaccine (MRC-5 cells) Zhifeilongkoma - 5-dose program

Inoculate 1 dose of Investigational vaccine each on 0, 3, 7, 14, 28 days, by intramuscular injection of deltoid muscle of upper arm

BIOLOGICAL

Freeze-dried human rabies vaccine (MRC-5 cells) Zhifeilongkoma - 4-dose program

Inoculate 1 dose of Investigational vaccine each on both arms on day 0, and 1 dose each on day 7 and 21, by intramuscular injection of deltoid muscle of upper arm

BIOLOGICAL

Freeze-dried human rabies vaccine (MRC-5 cells) Kanghua - 5-dose program

Inoculate 1 dose of Investigational vaccine each on 0, 3, 7, 14, 28 days, by intramuscular injection of deltoid muscle of upper arm

BIOLOGICAL

Freeze-dried human rabies vaccine (MRC-5 cells) Kanghua - 4-dose program

Inoculate 1 dose of Investigational vaccine each on both arms on day 0, and 1 dose each on day 7 and 21, by intramuscular injection of deltoid muscle of upper arm

Trial Locations (1)

410005

Hunan Provincial Center for Disease Control and Prevention, Changsha

All Listed Sponsors
collaborator

Sponsor GmbH

OTHER

lead

Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

INDUSTRY

NCT06078423 - A Clinical Trial of Freeze-dried Human Rabies Vaccine (MRC-5 Cells) | Biotech Hunter | Biotech Hunter